Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
BLIN vs HQY vs WEX vs DGII vs PCTY
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
Software - Infrastructure
Communication Equipment
Software - Application
BLIN vs HQY vs WEX vs DGII vs PCTY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Medical - Healthcare Information Services | Software - Infrastructure | Communication Equipment | Software - Application |
| Market Cap | $12M | $7.14B | $5.00B | $2.33B | $5.93B |
| Revenue (TTM) | $16M | $1.31B | $2.70B | $475M | $1.73B |
| Net Income (TTM) | $-2M | $215M | $310M | $43M | $258M |
| Gross Margin | 61.4% | 69.5% | 57.4% | 63.4% | 69.3% |
| Operating Margin | -11.9% | 24.6% | 24.7% | 13.2% | 21.3% |
| Forward P/E | — | 21.4x | 7.3x | 26.9x | 14.3x |
| Total Debt | $533K | $44M | $4.86B | $180M | $218M |
| Cash & Equiv. | $2M | $319M | $906M | $22M | $398M |
BLIN vs HQY vs WEX vs DGII vs PCTY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Bridgeline Digital,… (BLIN) | 100 | 60.0 | -40.0% |
| HealthEquity, Inc. (HQY) | 100 | 136.9 | +36.9% |
| WEX Inc. (WEX) | 100 | 95.7 | -4.3% |
| Digi International … (DGII) | 100 | 591.0 | +491.0% |
| Paylocity Holding C… (PCTY) | 100 | 85.4 | -14.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLIN vs HQY vs WEX vs DGII vs PCTY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BLIN lags the leaders in this set but could rank higher in a more targeted comparison.
HQY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.04
- Rev growth 9.5%, EPS growth 125.7%, 3Y rev CAGR 15.1%
- Lower volatility, beta 1.04, Low D/E 2.1%, current ratio 3.27x
- PEG 0.26 vs DGII's 0.87
Among these 5 stocks, WEX doesn't own a clear edge in any measured category.
DGII ranks third and is worth considering specifically for long-term compounding.
- 463.4% 10Y total return vs HQY's 228.2%
- +121.0% vs BLIN's -46.0%
PCTY is the #2 pick in this set and the best alternative if growth and stability is your priority.
- 13.7% revenue growth vs BLIN's 0.2%
- Beta 0.43 vs DGII's 1.40, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.7% revenue growth vs BLIN's 0.2% | |
| Value | PEG 0.26 vs 0.51 | |
| Quality / Margins | 16.4% margin vs BLIN's -12.7% | |
| Stability / Safety | Beta 0.43 vs DGII's 1.40, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +121.0% vs BLIN's -46.0% | |
| Efficiency (ROA) | 6.3% ROA vs BLIN's -12.5%, ROIC 10.2% vs -18.4% |
BLIN vs HQY vs WEX vs DGII vs PCTY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BLIN vs HQY vs WEX vs DGII vs PCTY — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HQY leads in 2 of 6 categories
BLIN leads 1 • DGII leads 1 • WEX leads 0 • PCTY leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HQY leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WEX is the larger business by revenue, generating $2.7B annually — 174.0x BLIN's $16M. HQY is the more profitable business, keeping 16.4% of every revenue dollar as net income compared to BLIN's -12.7%. On growth, DGII holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $16M | $1.3B | $2.7B | $475M | $1.7B |
| EBITDAEarnings before interest/tax | -$1M | $322M | $952M | $90M | $394M |
| Net IncomeAfter-tax profit | -$2M | $215M | $310M | $43M | $258M |
| Free Cash FlowCash after capex | -$1M | $439M | $460M | $130M | $470M |
| Gross MarginGross profit ÷ Revenue | +61.4% | +69.5% | +57.4% | +63.4% | +69.3% |
| Operating MarginEBIT ÷ Revenue | -11.9% | +24.6% | +24.7% | +13.2% | +21.3% |
| Net MarginNet income ÷ Revenue | -12.7% | +16.4% | +11.5% | +9.1% | +14.9% |
| FCF MarginFCF ÷ Revenue | -8.6% | +33.4% | +17.0% | +27.4% | +27.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.2% | +7.3% | +5.8% | +25.1% | +10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +83.6% | +93.3% | +22.7% | +3.6% | +26.7% |
Valuation Metrics
BLIN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 17.0x trailing earnings, WEX trades at a 70% valuation discount to DGII's 57.4x P/E. Adjusting for growth (PEG ratio), HQY offers better value at 0.41x vs DGII's 1.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12M | $7.1B | $5.0B | $2.3B | $5.9B |
| Enterprise ValueMkt cap + debt − cash | $11M | $6.9B | $9.0B | $2.5B | $5.8B |
| Trailing P/EPrice ÷ TTM EPS | -4.04x | 34.14x | 17.03x | 57.44x | 27.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.45x | 7.29x | 26.89x | 14.29x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.41x | — | 1.85x | 0.96x |
| EV / EBITDAEnterprise value multiple | — | 21.29x | 8.89x | 27.60x | 14.25x |
| Price / SalesMarket cap ÷ Revenue | 0.80x | 5.44x | 1.88x | 5.42x | 3.72x |
| Price / BookPrice ÷ Book value/share | 1.19x | 3.49x | 4.20x | 3.68x | 5.00x |
| Price / FCFMarket cap ÷ FCF | — | 15.69x | 15.94x | 22.15x | 17.31x |
Profitability & Efficiency
HQY leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WEX delivers a 27.0% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-21 for BLIN. HQY carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to WEX's 3.94x. On the Piotroski fundamental quality scale (0–9), HQY scores 9/9 vs BLIN's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -20.6% | +10.1% | +27.0% | +6.7% | +22.4% |
| ROA (TTM)Return on assets | -12.5% | +6.3% | +2.1% | +4.8% | +4.9% |
| ROICReturn on invested capital | -18.4% | +10.2% | +9.6% | +5.7% | +26.2% |
| ROCEReturn on capital employed | -20.6% | +9.8% | +13.4% | +7.3% | +23.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 9 | 5 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.06x | 0.02x | 3.94x | 0.28x | 0.18x |
| Net DebtTotal debt minus cash | -$1M | -$275M | $4.0B | $158M | -$180M |
| Cash & Equiv.Liquid assets | $2M | $319M | $906M | $22M | $398M |
| Total DebtShort + long-term debt | $533,000 | $44M | $4.9B | $180M | $218M |
| Interest CoverageEBIT ÷ Interest expense | -13.73x | 5.64x | 2.76x | 21.93x | 23.29x |
Total Returns (Dividends Reinvested)
DGII leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DGII five years ago would be worth $34,712 today (with dividends reinvested), compared to $4,226 for BLIN. Over the past 12 months, DGII leads with a +121.0% total return vs BLIN's -46.0%. The 3-year compound annual growth rate (CAGR) favors DGII at 25.7% vs PCTY's -14.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.2% | -7.8% | -2.8% | +43.7% | -25.1% |
| 1-Year ReturnPast 12 months | -46.0% | -8.4% | +19.0% | +121.0% | -40.6% |
| 3-Year ReturnCumulative with dividends | +9.8% | +56.0% | -18.2% | +98.5% | -37.1% |
| 5-Year ReturnCumulative with dividends | -57.7% | +12.7% | -26.5% | +247.1% | -35.2% |
| 10-Year ReturnCumulative with dividends | -99.5% | +228.2% | +60.9% | +463.4% | +218.2% |
| CAGR (3Y)Annualised 3-year return | +3.2% | +16.0% | -6.5% | +25.7% | -14.3% |
Risk & Volatility
Evenly matched — DGII and PCTY each lead in 1 of 2 comparable metrics.
Risk & Volatility
PCTY is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than DGII's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DGII currently trades 88.9% from its 52-week high vs BLIN's 47.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 1.02x | 1.07x | 1.35x | 0.39x |
| 52-Week HighHighest price in past year | $2.14 | $116.65 | $186.85 | $69.81 | $201.97 |
| 52-Week LowLowest price in past year | $0.69 | $72.90 | $120.03 | $27.71 | $92.99 |
| % of 52W HighCurrent price vs 52-week peak | +47.2% | +72.0% | +77.2% | +88.9% | +54.0% |
| RSI (14)Momentum oscillator 0–100 | 60.8 | 52.7 | 38.0 | 69.3 | 45.7 |
| Avg Volume (50D)Average daily shares traded | 26K | 876K | 518K | 268K | 733K |
Analyst Outlook
Evenly matched — HQY and WEX each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HQY as "Buy", WEX as "Hold", DGII as "Buy", PCTY as "Buy". Consensus price targets imply 35.4% upside for PCTY (target: $148) vs 10.0% for DGII (target: $68).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $109.89 | $177.67 | $68.25 | $147.73 |
| # AnalystsCovering analysts | — | 27 | 32 | 18 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 | 2 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.7% | +4.2% | +16.0% | 0.0% | +2.5% |
HQY leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BLIN leads in 1 (Valuation Metrics). 2 tied.
BLIN vs HQY vs WEX vs DGII vs PCTY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BLIN or HQY or WEX or DGII or PCTY a better buy right now?
For growth investors, Paylocity Holding Corporation (PCTY) is the stronger pick with 13.
7% revenue growth year-over-year, versus 0. 2% for Bridgeline Digital, Inc. (BLIN). WEX Inc. (WEX) offers the better valuation at 17. 0x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate HealthEquity, Inc. (HQY) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLIN or HQY or WEX or DGII or PCTY?
On trailing P/E, WEX Inc.
(WEX) is the cheapest at 17. 0x versus Digi International Inc. at 57. 4x. On forward P/E, WEX Inc. is actually cheaper at 7. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: HealthEquity, Inc. wins at 0. 26x versus Digi International Inc. 's 0. 87x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BLIN or HQY or WEX or DGII or PCTY?
Over the past 5 years, Digi International Inc.
(DGII) delivered a total return of +247. 1%, compared to -57. 7% for Bridgeline Digital, Inc. (BLIN). Over 10 years, the gap is even starker: DGII returned +497. 5% versus BLIN's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLIN or HQY or WEX or DGII or PCTY?
By beta (market sensitivity over 5 years), Paylocity Holding Corporation (PCTY) is the lower-risk stock at 0.
39β versus Digi International Inc. 's 1. 35β — meaning DGII is approximately 246% more volatile than PCTY relative to the S&P 500. On balance sheet safety, HealthEquity, Inc. (HQY) carries a lower debt/equity ratio of 2% versus 4% for WEX Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BLIN or HQY or WEX or DGII or PCTY?
By revenue growth (latest reported year), Paylocity Holding Corporation (PCTY) is pulling ahead at 13.
7% versus 0. 2% for Bridgeline Digital, Inc. (BLIN). On earnings-per-share growth, the picture is similar: HealthEquity, Inc. grew EPS 125. 7% year-over-year, compared to -31. 6% for Bridgeline Digital, Inc.. Over a 3-year CAGR, PCTY leads at 23. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLIN or HQY or WEX or DGII or PCTY?
HealthEquity, Inc.
(HQY) is the more profitable company, earning 16. 4% net margin versus -16. 4% for Bridgeline Digital, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WEX leads at 25. 4% versus -14. 2% for BLIN. At the gross margin level — before operating expenses — HQY leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLIN or HQY or WEX or DGII or PCTY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, HealthEquity, Inc. (HQY) is the more undervalued stock at a PEG of 0. 26x versus Digi International Inc. 's 0. 87x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, WEX Inc. (WEX) trades at 7. 3x forward P/E versus 26. 9x for Digi International Inc. — 19. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PCTY: 35. 4% to $147. 73.
08Which pays a better dividend — BLIN or HQY or WEX or DGII or PCTY?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is BLIN or HQY or WEX or DGII or PCTY better for a retirement portfolio?
For long-horizon retirement investors, Paylocity Holding Corporation (PCTY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
39), +223. 7% 10Y return). Both have compounded well over 10 years (PCTY: +223. 7%, WEX: +58. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLIN and HQY and WEX and DGII and PCTY?
These companies operate in different sectors (BLIN (Technology) and HQY (Healthcare) and WEX (Technology) and DGII (Technology) and PCTY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BLIN is a small-cap quality compounder stock; HQY is a small-cap quality compounder stock; WEX is a small-cap deep-value stock; DGII is a small-cap quality compounder stock; PCTY is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.